Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders
Abstract
:1. Introduction
2. Methods
2.1. Data Source
2.2. Inclusion Criteria and Variables
2.3. Statistical Analysis
2.4. Ethical Approval
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Prevention, Centers for Disease Control and Prevention. Today’s Heroin Epidemic. 2015. Available online: https://www.cdc.gov/vitalsigns/heroin/index.html (accessed on 15 April 2019).
- Results from the 2017 National Survey on Drug Use and Health: Detailed Tables. 2018. Available online: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdf (accessed on 15 April 2019).
- Huang, X.; Keyes, K.M.; Li, G. Increasing Prescription Opioid and Heroin Overdose Mortality in the United States, 1999–2014: An Age-Period-Cohort Analysis. Am. J. Public Health 2018, 108, 131–136. [Google Scholar] [CrossRef] [PubMed]
- Results from the 2015 National Survey on Drug Use and Health: Detailed Tables. 2016. Available online: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf (accessed on 15 April 2019).
- Association, Associated Press. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; Psychiatric Publishing: Arlington, VA, USA, 2015. [Google Scholar]
- Moses, T.E.H.; Lundahl, L.H.; Greenwald, M.K. Factors associated with sedative use and misuse among heroin users. Drug Alcohol Depend. 2018, 185, 10–16. [Google Scholar] [CrossRef] [PubMed]
- Case, A.; Deaton, A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc. Natl. Acad. Sci. USA 2015, 112, 15078–15083. [Google Scholar] [CrossRef] [Green Version]
- Curtin, S.C.; Tejada-Vera, B.; Warner, M. Drug Overdose Deaths among Adolescents Aged 15–19 in the United States: 1999–2015; National Center for Health Statistics: Hyattsville, MD, USA, 2017.
- McCabe, S.E.; Veliz, P.; Boyd, C.J.; Schulenberg, J.E. Medical and nonmedical use of prescription sedatives and anxiolytics: Adolescents’ use and substance use disorder symptoms in adulthood. Addict. Behav. 2017, 65, 296–301. [Google Scholar] [CrossRef] [PubMed]
- Healthcare Cost and Utilization Project (HCUP) (Ed.) HCUP NIS Database Documentation; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2018.
- Healthcare Cost and Utilization Project (HCUP) CCS. 2017. Available online: https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp (accessed on 9 June 2018).
- Clinton, H.A.; Hunter, A.A.; Logan, S.B.; Lapidus, G.D. Evaluating opioid overdose using the National Violent Death Reporting System, 2016. Drug Alcohol Depend. 2019, 194, 371–376. [Google Scholar] [CrossRef] [PubMed]
- Young, A.M.; Glover, N.; Havens, J.R. Nonmedical use of prescription medications among adolescents in the United States: A systematic review. J. Adolesc. Health 2012, 51, 6–17. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez-Llera, M.C.; Domingo-Salvany, A.; Brugal, M.T.; Silva, T.C.; Sánchez-Niubó, A.; Torrens, M.; Itinere Investigators. Psychiatric comorbidity in young heroin users. Drug Alcohol Depend. 2006, 84, 48–55. [Google Scholar] [CrossRef] [PubMed]
- Ruhm, C.J. Drug involvement in fatal overdoses. SSM Popul. Health 2017, 3, 219–226. [Google Scholar] [CrossRef] [PubMed]
- Warner, M.; Trinidad, J.P.; Bastian, B.A.; Miniño, A.M.; Hedegaard, H. Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2010–2014. Natl. Vital. Stat. Rep. 2016, 65, 1–15. [Google Scholar] [PubMed]
- Trim, R.S.; Chassin, L. Neighborhood socioeconomic status effects on adolescent alcohol outcomes using growth models: Exploring the role of parental alcoholism. J. Stud. Alcohol Drugs 2008, 69, 639–648. [Google Scholar] [CrossRef] [PubMed]
- Gaither, J.R.; Shabanova, V.; Leventhal, J.M. US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999–2016. JAMA Network Open 2018, 1, e186558. [Google Scholar] [CrossRef] [PubMed]
- Kane, J.M.; Colvin, J.D.; Bartlett, A.H.; Hall, M. Opioid-Related Critical Care Resource Use in US Children’s Hospitals. Pediatrics 2018, 141, e20173335. [Google Scholar] [CrossRef] [PubMed]
- Substance Abuse and Suicide: A Guide to Understanding the Connection and Reducing Risk. Available online: https://www.drugrehab.com/guides/suicide-risks/ (accessed on 15 May 2019).
- Dragisic, T.; Dickov, A.; Dickov, V.; Mijatovic, V. Drug Addiction as Risk for Suicide Attempts. Mater. Sociomed 2015, 27, 188–191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Opioid Overdose. 2018. Available online: https://www.cdc.gov/drugoverdose/opioids/heroin.html (accessed on 15 May 2019).
- Yule, A.M.; Lyons, R.M.; Wilens, T.E. Opioid Use Disorders in Adolescents-Updates in Assessment and Management. Curr. Pediatr. Rep. 2018, 6, 99–106. [Google Scholar] [CrossRef] [PubMed]
- Ho, R.C.; Chen, K.Y.; Broekman, B.; Mak, A. Buprenorphine: aspects of prescription, misuse and service provision from a global perspective. Adv. Psychiatr. Treat. 2009, 15, 354–363. [Google Scholar] [CrossRef]
- Ho, R.C.; Ho, E.C.; Tan, C.H.; Mak, A. Pulmonary Hypertension in First Episode Infective Endocarditis among Intravenous Buprenorphine Users. Am. J. Drug Alcohol Abus. 2009, 35, 199–202. [Google Scholar] [CrossRef]
- Ho, R.C.; Ho, E.C.; Mak, A. Cutaneous Complications among Intravenous Buprenorphine Users. J. Dermatol. 2009, 36, 24–31. [Google Scholar] [CrossRef] [PubMed]
- Normile, B.; Hanlon, C.; Eichner, H. State Strategies to Meet the Needs of Young Children and Families Affected by the Opioid Crisis; The National Academy for State Health Policy: Washington, DC, USA, 2018. [Google Scholar]
- Intervention IDEAs for Infants Toddlers Children and Youth Impacted by Opioids. Available online: https://osepideasthatwork.org/sites/default/files/IDEAslIssBrief-Opioids-508.pdf (accessed on 15 May 2019).
Variable | Non-HOD (%) | HOD (%) | OR | 95% CI | p Value |
---|---|---|---|---|---|
Total inpatients | 27,442,808 | 1432 | - | - | - |
Age at admission, in years | |||||
<11 | 88.9 | 4.6 | Reference | ||
12–18 | 11. | 95.4 | 56.38 | 43.36–73.30 | <0.001 |
Sex | |||||
Male | 51.0 | 57.2 | 1.46 | 1.30–1.64 | <0.001 |
Female | 49.0 | 42.8 | Reference | ||
Race | |||||
White | 51.3 | 81.0 | Reference | ||
Black | 15.8 | 1.9 | 0.18 | 0.12–0.27 | <0.001 |
Hispanic | 21.4 | 10.8 | 0.80 | 0.66–0.97 | 0.023 |
NA/Asian | 11.5 | 6.3 | 0.97 | 0.77–1.23 | 0.819 |
Median household income, in percentile | |||||
0–25th | 29.0 | 12.6 | Reference | ||
26th–50th | 25.1 | 20.9 | 1.41 | 1.15–1.72 | 0.001 |
51st–75th | 24.6 | 26.5 | 1.77 | 1.47–2.14 | <0.001 |
76th–100th | 21.3 | 40.0 | 2.38 | 1.99–2.84 | <0.001 |
Comorbid psychiatric disorders | |||||
Anxiety disorders | 1.4 | 20.4 | 1.21 | 1.05–1.40 | 0.010 |
Mood disorders | 3.0 | 43.8 | 1.06 | 0.930–1.21 | 0.386 |
Suicidality | 1.0 | 3.1 | 0.19 | 0.14–0.25 | <0.001 |
Psychotic disorders | 0.3 | 1.0 | 0.42 | 0.25–0.70 | 0.001 |
Comorbid substance use disorders | |||||
Tobacco | 0.6 | 36.8 | 1.73 | 1.51–1.98 | <0.001 |
Cannabis | 0.6 | 28.5 | 0.83 | 0.72–0.96 | 0.011 |
Opioid | 0.1 | 62.4 | 195.68 | 167.71–228.32 | <0.001 |
Amphetamine | 0 | 7.1 | 1.03 | 0.81–1.32 | 0.814 |
Cocaine | 0 | 9.4 | 1.45 | 1.12–1.76 | <0.001 |
Variable | 2010 (%) | 2011 (%) | 2012 (%) | 2013 (%) | 2014 (%) | p Value |
---|---|---|---|---|---|---|
Total inpatients | 289 | 258 | 295 | 305 | 235 | - |
Age at admission, in years | ||||||
<11 | 5.5 | 0 | 3.3 | 3.2 | 11.3 | 0.001 |
12–18 | 94.5 | 100.0 | 96.7 | 96.8 | 88.7 | |
Sex | ||||||
Male | 60.9 | 61.2 | 49.2 | 57.1 | 58.5 | 0.336 |
Female | 39.1 | 38.8 | 50.8 | 42.9 | 41.5 | |
Race | ||||||
White | 80.9 | 79.1 | 77.2 | 91.2 | 75.0 | 0.726 |
Black | 0 | 4.0 | 3.5 | 1.8 | 0 | |
Hispanic | 13.0 | 8.4 | 12.3 | 5.3 | 15.9 | |
NA/Asian | 6.1 | 8.4 | 7.0 | 1.8 | 9.1 | |
Median household income, in percentile | ||||||
0–25th | 12.5 | 12.3 | 13.6 | 17.7 | 5.8 | 0.294 |
26th–50th | 21.9 | 30.4 | 13.6 | 16.1 | 25.0 | |
51st–75th | 24.3 | 22.5 | 28.8 | 25.8 | 30.8 | |
76th–100th | 41.3 | 34.8 | 44.1 | 40.3 | 38.5 | |
Comorbid psychiatric disorders | ||||||
Anxiety disorders | 20.8 | 18.2 | 16.4 | 25.4 | 20.8 | 0.329 |
Mood disorders | 40.5 | 40.7 | 49.2 | 42.9 | 45.3 | 0.221 |
Suicidality | 1.7 | 1.9 | 4.9 | 1.6 | 5.7 | 0.032 |
Psychotic disorders | 3.5 | 0 | 1.6 | 0 | 0 | <0.001 |
Comorbid substance use disorders | ||||||
Tobacco | 28.7 | 40.3 | 32.8 | 44.4 | 37.7 | 0.009 |
Cannabis | 28.8 | 22.9 | 32.8 | 30.2 | 26.4 | 0.773 |
Opioid | 46.9 | 55.6 | 65.6 | 74.6 | 67.9 | <0.001 |
Amphetamine | 5.2 | 6.6 | 6.6 | 11.1 | 5.7 | 0.201 |
Cocaine | 7.3 | 7.4 | 9.8 | 11.1 | 11.3 | 0.032 |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Queeneth, U.; Bhimanadham, N.N.; Mainali, P.; Onyeaka, H.K.; Pankaj, A.; Patel, R.S. Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders. Behav. Sci. 2019, 9, 77. https://doi.org/10.3390/bs9070077
Queeneth U, Bhimanadham NN, Mainali P, Onyeaka HK, Pankaj A, Patel RS. Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders. Behavioral Sciences. 2019; 9(7):77. https://doi.org/10.3390/bs9070077
Chicago/Turabian StyleQueeneth, Uwandu, Narmada N. Bhimanadham, Pranita Mainali, Henry K. Onyeaka, Amaya Pankaj, and Rikinkumar S. Patel. 2019. "Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders" Behavioral Sciences 9, no. 7: 77. https://doi.org/10.3390/bs9070077
APA StyleQueeneth, U., Bhimanadham, N. N., Mainali, P., Onyeaka, H. K., Pankaj, A., & Patel, R. S. (2019). Heroin Overdose-Related Child and Adolescent Hospitalizations: Insight on Comorbid Psychiatric and Substance Use Disorders. Behavioral Sciences, 9(7), 77. https://doi.org/10.3390/bs9070077